Transmission of cell-free and cell-associated HIV-1 through breast-feeding

Journal of Acquired Immune Deficiency Syndromes

Volumn 41, Issue 1, 2006, Pages 93-99

  Koulinska, Irene N ^a   Villamor, Eduardo ^b   Chaplin, Beth ^a   Msamanga, Gernard ^c   Fawzi, Wafaie ^b   Renjifo, Boris ^a   Essex, Max ^a  

^a Harvard AIDS Institute   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MUHIMBILI MEDICAL CENTRE   (Tanzania)

Author keywords

Breast feeding; HIV 1; Mother to child transmission; Provirus

Indexed keywords

CD4 ANTIGEN;

ADULT; ARTICLE; BREAST FEEDING; BREAST MILK; CELL COUNT; CELL FREE SYSTEM; CONTROLLED STUDY; DISEASE TRANSMISSION; ENVELOPE GENE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; PROVIRUS; PUERPERIUM; UNINDEXED SEQUENCE; VIRUS LOAD;

ADULT; BREAST FEEDING; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; CELL-FREE SYSTEM; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GENE PRODUCTS, ENV; HIV SEROPOSITIVITY; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; MILK, HUMAN; MOLECULAR SEQUENCE DATA; PLACEBOS; REGRESSION ANALYSIS; TANZANIA; VITAMINS;

EID: 28944437322     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000179424.19413.24     Document Type: Article

References (50)

1. Petra Study Team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Lancet. 2002;359:1178-1186.
2. Coutsoudis A, Goga AE, Rollins N, et al. Free formula milk for infants of HIV-infected women: blessing or curse? Health Policy Plan. 2002;17:154-160.
3. Fawzi W, Msamanga G, Spiegelman D, et al. Transmission of HIV-1 through breast-feeding among women in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr. 2002;31:331-338.
4. Coutsoudis A, Dabis F, Fawzi W, et al. Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis. 2004;189:2154-2166.
5. Embree J, Njenga S, Datta P, et al. Risk factors for postnatal mother-child transmission of HIV-1. AIDS. 2000;14:2535-2541.
6. Semba RD, Kumwenda N, Taha TE, et al. Mastitis and immunological factors in breast milk of human immunodeficiency virus-infected women. J Hum Lab. 1999;15:301-306.
7. Moore JS, Rahemtulla F, Kent LW, et al. Oral epithelial cells are susceptible to cell-free and cell-associated HIV-1 infection in vitro. Virology. 2003;2:343-353.
8. Liu X, Zha J, Chen H, et al. Human immunodeficiency virus type 1 infection and replication in normal human oral keratinocytes. J Virol. 2003;77:3470-3476.
9. Van de Perre P. Breast milk transmission of HIV-1. Laboratory and clinical studies. Ann NY Acad Sci. 2000;918:122-127.
10. Owen R. M cells as portals of entry for HIV. Pathobiology. 1998;66:141-144.
11. Meng G, Wei X, Wu X, et al. Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells. Nat Med. 2002;2:150-156.
12. Bomsel M, David V. Mucosal gatekeepers: selecting HIV viruses for early infection. Nat Med. 2002;8:114-116.
13. Bomsel M. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat Med. 1997;3:42-47.
14. Nduati RW, John GC, Richardson BA, et al. Human immunodeficiency virus type 1-infected cells in breast milk: association with immunosuppression and vitamin A deficiency. J Infect Dis. 1995;172:1461-1468.
15. Lewis P, Nduati R, Kreiss JK, et al. Cell-free human immunodeficiency virus type 1 in breast milk. J Infect Dis. 1998;177:34-39.
16. Rousseau CM, Nduati RW, Richardson BA, et al. Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease. J Infect Dis. 2003;7:741-747.
17. Pillay K, Coutsoudis A, York D, et al. Cell-free virus in breast milk of HIV-1-seropositive women. J Acquir Immune Defic Syndr. 2000;24:330-336.
18. Willumsen JF, Newell ML, Filteau SM, et al. Variation in breastmilk HIV-1 viral load in left and right breasts during the first 3 months of lactation. AIDS. 2001;15:1896-1898.
19. Semba RD, Kumwenda N, Hoover DR, et al. Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis. 1999;180:93-98.
20. John GC, Nduati RW, Mbori-Ngacha DA, et al. Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis. 2001;183:206-212.
21. Montano M, Russell M, Gilbert P, et al. Comparative prediction of perinatal human immunodeficiency virus type 1 transmission, using multiple virus load markers. J Infect Dis. 2003;188:406-413.
22. Parekh BS, Shaffer N, Coughlin R, et al. Dynamics of maternal IgG antibody decay and HIV-specific antibody synthesis in infants born to seropositive mothers. The NYC Perinatal HIV Transmission Study Group. AIDS Res Hum Retroviruses. 1993;9:907-912.
23. Goldman AS, Garza C, Nichols BL, et al. Immunologic factors in human milk during the first year of lactation. J Pediatr. 1982;100:563-567.
24. Fawzi WW, Msamanga GI, Spiegelman D, et al. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet. 1998;351:1477-1482.
25. Fawzi W, Msamanga G, Hunter D, et al. Randomized trial of vitamin supplements in relation to vertical transmission of HIV-1 in Tanzania. J Acquir Immune Defic Syndr. 2000;23:246-254.
26. The WHO International Collaborating Group for the Study of the WHO Staging System. Proposed "World Health Organization staging system for HIV infection and disease": preliminary testing by an international collaborative cross-sectional study. AIDS. 1993;7:711-718.
27. Renjifo B, Gilbert P, Chaplin B, et al. Emerging recombinant human immunodeficiency viruses: uneven representation of the envelope V3 region. AIDS. 1999;13:1613-1621.
28. Renjifo B, Gilbert P, Chaplin B, et al. Preferential in-utero transmission of HIV-1 subtype C compared to subtype A or D. AIDS. 2004;18:1629-1636.
29. Ndung'u T, Renjifo B, Essex M. Construction and analysis of an infectious human immunodeficiency virus type 1 subtype C molecular clone. J Virol. 2001;75:4964-4972.
30. Jeanmougin F, Thompson JD, Gouy M, et al. Multiple sequence alignment with Clustal X. Trends Biochem Sci. 1998;23:403-405.
31. Carr J, Foley B, Leitner T, et al. Reference Sequences Representing the Principal Genetic Diversity of HIV-1 in the Pandemic. Los Alamos, NM: Theoretical Biology and Biophysics Group, Los Alamos National Laboratory; 1998.
32. Fawzi WW, Msamanga GI, Hunter D, et al. Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breast-feeding and early child mortality. AIDS. 2002;16:1935-1944.
33. Moodley D, Bobat RA, Coutsoudis A, et al. Predicting perinatal human immunodeficiency virus infection by antibody patterns. Pediatr Infect Dis J. 1995;14:850-852.
34. Simmonds P, Balfe P, Peutherer JF, et al. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J Virol. 1990;64:864-872.
35. Bagasra O, Hauptman SP, Lischner HW, et al. Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction. N Engl J Med. 1992;326:1385-1391.
36. Escaich S, Ritter J, Rougier P, et al. Relevance of the quantitative detection of HIV proviral sequences in PBMC of infected individuals. AIDS Res Hum Retroviruses. 1992;8:1833-1837.
37. Desire N, Dehee A, Schneider V, et al. Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay. J Clin Microbiol. 2001;39:1303-1310.
38. Kourtis AP, Butera S, Ibegbu C, et al. Breast milk and HIV-1: vector of transmission or vehicle of protection? Lancet Infect Dis. 2003;3:786-793.
39. Ruff AJ, Coberly J, Halsey NA, et al. Prevalence of HIV-1 DNA and p24 antigen in breast milk and correlation with maternal factors. J Acquir Immune Defic Syndr. 1994;7:68-73.
40. Guay LA, Hom DL, Mmiro F, et al. Detection of human immunodeficiency virus type 1 (HIV-1 ) DNA and p24 antigen in breast milk of HIV-1-infected Ugandan women and vertical transmission. Pediatrics. 1996;98:438-444.
41. Amedee AM, Rychert J, Lacour N, et al. Viral and immunological factors associated with breast milk transmission of SIV in rhesus macaques. Retrovirology. 2004;1:17.
42. Van de Perre P, Simonon A, Hitimana DG, et al. Infective and anti-infective properties of breastmilk from HIV-1-infected women. Lancet. 1993;341:914-918.
43. Rousseau CM, Nduati RW, Richardson BA, et al. Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. J Infect Dis. 2004;190:1880-1888.
44. Farquhar C, Van Cott TC, Mbori-Ngacha DA, et al. Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk. J Infect Dis. 2002;186:1173-1176.
45. Cuilliere ML, Montagne P, Mole C, et al. Microparticle-enhanced nephelometric immunoassay of lactoferrin in human milk. J Clin Lab Anal. 1997;11:239-243.
46. Tregoat V, Montagne P, Bene MC, et al. Changes in the mannan binding lectin (MBL) concentration in human milk during lactation. J Clin Lab Anal. 2002;16:304-307.
47. Wahl SM, McNeely TB, Janoff EN, et al. Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV-1. Oral Dis. 1997;3(Suppl 1):S64-S69.
48. Becquart P, Gresenguet G, Hocini H, et al. Secretory leukocyte protease inhibitor in colostrum and breast milk is not a major determinant of the protection of early postnatal transmission of HIV AIDS. 1999;13:2599-2602.
49. Bertotto A, Gerli R, Fabietti G, et al. Human breast milk T lymphocytes display the phenotype and functional characteristics of memory T cells. Eur J Immunol. 1990;1990:8.
50. Goldman AS, Chheda S, Garofalo R. Evolution of immunologic functions of the mammary gland and the postnatal development of immunity. Pediatr Res. 1998;43:155-162.